Additionally, targeting newer GSC-specific markers, such as the stem-like cell marker SOX2 that promotes tumour progression [136] or SOCS3, USP8, and DOT1L, which were recently linked to GSC growth, may be more efficient [137]. Here, DOT1L is linked to neoplasm.